{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T23:16:27Z","timestamp":1783811787898,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T00:00:00Z","timestamp":1382659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1038\/eye.2013.232","type":"journal-article","created":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T09:34:50Z","timestamp":1382693690000},"page":"53-57","source":"Crossref","is-referenced-by-count":16,"title":["Long-term efficacy of latanoprost in primary congenital glaucoma"],"prefix":"10.1038","volume":"28","author":[{"given":"M G","family":"Uva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Avitabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Reibaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bucolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Drago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Quaranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Lionetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,25]]},"reference":[{"key":"BFeye2013232_CR1","unstructured":"European glaucoma society. Terminology and Guidelines for Glaucoma 3rd edn. Editrice Dogma: Savona, Italy, 2008 pp 93\u201394."},{"key":"BFeye2013232_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S0181-5512(06)73774-3","volume":"29","author":"P Dureau","year":"2006","unstructured":"Dureau P . Congenital glaucoma and trabeculodysgenesis. Clinical and genetic aspects. J Fr Ophtalmol 2006; 29: 198\u2013215.","journal-title":"J Fr Ophtalmol"},{"key":"BFeye2013232_CR3","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/S0161-6420(84)34141-0","volume":"91","author":"MS Passo","year":"1984","unstructured":"Passo MS, Palmer EA, Van Buskirk EM . Plasma timolol in glaucoma patients. Ophthalmology 1984; 91: 1361\u20131363.","journal-title":"Ophthalmology"},{"key":"BFeye2013232_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/000992280404300114","volume":"43","author":"Y Levy","year":"2004","unstructured":"Levy Y, Zadok D . Systemic side effects of ophthalmic drops. Clin Pediatr 2004; 43: 99\u2013101.","journal-title":"Clin Pediatr"},{"key":"BFeye2013232_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.coph.2012.09.012","volume":"13","author":"C Bucolo","year":"2013","unstructured":"Bucolo C, Salomone S, Drago F, Reibaldi M, Longo A, Uva MG . Pharmacological management of ocular hypertension: current approaches and future prospective. Curr Opin Pharmacol 2013; 13: 50\u201355.","journal-title":"Curr Opin Pharmacol"},{"key":"BFeye2013232_CR6","unstructured":"European glaucoma society. Terminology and Guidelines for Glaucoma 3rd edn. Editrice Dogma: Savona, Italy, 2008 pp 136\u2013138."},{"key":"BFeye2013232_CR7","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S0002-9394(98)00129-9","volume":"126","author":"CB Yang","year":"1998","unstructured":"Yang CB, Freedman SF, Myers JS, Buckley EG, Herndon LW, Allingham RR . Use of latanoprost in the treatment of glaucoma associated with Sturge-Weber syndrome. Am J Ophthalmol 1998; 126: 600\u2013602.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2013232_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1091-8531(99)70092-3","volume":"3","author":"LB Enyedi","year":"1999","unstructured":"Enyedi LB, Freedman SF, Buckley EG . The effectiveness of latanoprost for the treatment of pediatric glaucoma. J AAPOS 1999; 3: 33\u201339.","journal-title":"J AAPOS"},{"key":"BFeye2013232_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0039-6257(02)00303-X","volume":"47","author":"LB Enyedi","year":"2002","unstructured":"Enyedi LB, Freedman SF . Latanoprost for the treatment of pediatric glaucoma. Surv Ophthalmol 2002; 47: 129\u2013132.","journal-title":"Surv Ophthalmol"},{"key":"BFeye2013232_CR10","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jaapos.2009.10.003","volume":"13","author":"AC Black","year":"2009","unstructured":"Black AC, Jones S, Yanovitch TL, Enyedi LB, Stinnett SS, Freedman SF . Latanoprost in pediatric glaucoma\u2014pediatric exposure over a decade. J AAPOS 2009; 13: 558\u2013562.","journal-title":"J AAPOS"},{"key":"BFeye2013232_CR11","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.ophtha.2011.03.010","volume":"118","author":"T Maeda-Chubachi","year":"2011","unstructured":"Maeda-Chubachi T, Chi-Burris K, Simons BD, Freedman SF, Khaw PT, Wirostko B et al. A6111137 Study Group. Comparison of latanoprost and timolol in pediatric glaucoma: a phase 3, 12-week, randomized, double-masked multicenter study. Ophthalmology 2011; 118: 2014\u20132021.","journal-title":"Ophthalmology"},{"key":"BFeye2013232_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1136\/bjo.2004.047761","volume":"89","author":"A Al-Hazmi","year":"2005","unstructured":"Al-Hazmi A, Awad A, Zwaan J, Al-Mesfer SA, Al-Jadaan I, Al-Mohammed A . Correlation between surgical success rate and severity of congenital glaucoma. Br J Ophthalmol 2005; 89: 449\u2013453.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2013232_CR13","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/IJG.0b013e31824d4fb9","volume":"22","author":"T Maeda-Chubachi","year":"2013","unstructured":"Maeda-Chubachi T, Chi-Burris K, Simons B, Br\u00e9mond-Gignac D, Freedman S, Khaw PT et alA6111137 Study Group. Impact of age, diagnosis, and history of glaucoma surgery on outcomes in pediatric patients treated with latanoprost. J Glaucoma 2013; 22: 614\u2013619.","journal-title":"J Glaucoma"},{"key":"BFeye2013232_CR14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3928\/0191-3913-19980701-05","volume":"35","author":"P Dureau","year":"1998","unstructured":"Dureau P, Dollfus H, Cassegrain C, Dufier JL . Long-term results of trabeculectomy for congenital glaucoma. J Pediatr Ophthalmol Strabismus 1998; 35: 198\u2013202.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"BFeye2013232_CR15","unstructured":"Uva MG, Longo A, Cannemi V, Reibaldi A . Efficacy and Safety of Latanoprost in Congenital Glaucoma. Invest Ophthalmol Vis Sci 2003; 44, E-Abstract 2163."},{"key":"BFeye2013232_CR16","first-page":"555","volume":"75","author":"MJ Le Rebeller","year":"1975","unstructured":"Le Rebeller MJ, Lagoutte F . Spontaneous resolution of a case of congenital glaucoma. Bull Soc Ophtalmol Fr 1975; 75: 555\u2013559.","journal-title":"Bull Soc Ophtalmol Fr"},{"key":"BFeye2013232_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1442-9071.1989.tb00490.x","volume":"17","author":"P Lockie","year":"1989","unstructured":"Lockie P, Elder J . Spontaneous resolution of primary congenital glaucoma. Aust N Z J Ophthalmol 1989; 17: 75\u201377.","journal-title":"Aust N Z J Ophthalmol"},{"key":"BFeye2013232_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3928\/01913913-20090505-04","volume":"46","author":"K Nagao","year":"2009","unstructured":"Nagao K, No\u00ebl LP, No\u00ebl ME, Walton DS . The spontaneous resolution of primary congenital glaucoma. J Pediatr Ophthalmol Strabismus 2009; 46: 139\u2013143.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"suppl 1","key":"BFeye2013232_CR19","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.survophthal.2008.08.004","volume":"53","author":"A Alm","year":"2008","unstructured":"Alm A, Grierson I, Shields MB. . Side effects associated with prostaglandin analog therapy. Surv Ophthalmol 2008; 53 (suppl 1): S93\u2013105.","journal-title":"Surv Ophthalmol"},{"key":"BFeye2013232_CR20","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1001\/archopht.126.5.626","volume":"126","author":"DM Albert","year":"2008","unstructured":"Albert DM, Gangnon RE, Grossniklaus HE, Green WR, Darjatmoko S, Kulkarni AD . A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides. Arch Ophthalmol 2008; 126: 626\u2013631.","journal-title":"Arch Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2013232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2013232","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2013232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:19:58Z","timestamp":1684430398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2013232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,25]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["BFeye2013232"],"URL":"https:\/\/doi.org\/10.1038\/eye.2013.232","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,25]]}}}